Intervention | Disease | Target proposed in GP contract | Estimate of level currently being achieved | No of CVD events prevented over 5 year period | |
---|---|---|---|---|---|
45–64 years | 65–84 years | ||||
CHD = coronary heart disease; ACE = angiotensin converting enzyme; A2 = angiotensin 2; HF = heart failure; CVD = cardiovascular disease. | |||||
*Events prevented by influenza vaccination refer to influenza mortality and not cardiovascular events. | |||||
Cholesterol lowering treatment | CHD | 60% ⩽5.0 | 26%9 | 21%9 | 15.5 |
Stroke | 30%9 | 23%9 | 7.2 | ||
Diabetes | 30%9 | 30%9 | 6.5 | ||
Blood pressure lowering treatment | CHD | 70% ⩽150/90 | 76%9 | 60%9 | 3.6 |
Stroke | 70% ⩽150/90 | 72%9 | 49%9 | 2.9 | |
Diabetes | 55% ⩽145/85 | 45%9 | 38%9 | 2.9 | |
Hypertension | 70% ⩽150/90 | 56%9 | 32%9 | 15.5 | |
Aspirin | CHD | 90% | 81%12 | 81%12 | 1.1 |
Stroke | 90% | 81%12 | 81%12 | 0.4 | |
ACE inhibitors/A2 antagonists | CHD and HF | 70% | 74%13 | 59%13 | 1.2 |
Influenza vaccination | CVD | 85% | 56%12 | 85%12 | 0.03* |